Bin Liang

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

Medicine, Oncology, Pharmacology +10

HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis

Zhijun Meng, Hongping Liang, Jianli Zhao et al. · Life Sciences · 2021 · 208 citations

Life Sciences, Biochemistry, Cell Biology +14

TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients

Jianqi Zhao, Hongxuan Fan, Ting Wang et al. · Cardiovascular Diabetology · 2022 · 197 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs

Bin Liang, Xin Wang, Nana Zhang et al. · Cellular Physiology and Biochemistry · 2015 · 83 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Lysophospholipid Receptors, as Novel Conditional Danger Receptors and Homeostatic Receptors Modulate Inflammation—Novel Paradigm and Therapeutic Potential

Xin Wang, Yafeng Li, Gayani Nanayakkara et al. · Journal of Cardiovascular Translational Research · 2016 · 68 citations

Life Sciences, Immunology, Molecular Biology +13